Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The androgen receptor mRNA.

Bu B Yeap1, Jackie A Wilce, Peter J Leedman

  • 1School of Medicine and Pharmacology, The University of Western Australia, Fremantle and Royal Perth Hospitals, Perth, Western Australia, Australia.

Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|June 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frailty Trajectories in Men Aged 71 Years or Older Living in Western Australia: Results From the Health in Men Study.

Journal of the American Medical Directors Association·2026
Same author

Associations of testosterone, sex hormone-binding globulin, and related hormones with risks of cancer death, incident cancer, and incident prostate cancer in men: individual participant data meta-analyses.

The lancet. Healthy longevity·2026
Same author

Epilepsy and risk of psychiatric disorders in later life: a population-based cohort study of 38,173 older men.

Epilepsy & behavior : E&B·2026
Same author

Natural history of thyroid function in ageing: an individual participant data analysis of 137 488 participants from 31 prospective cohort studies.

The lancet. Diabetes & endocrinology·2026
Same author

Early outcomes from a new multidisciplinary cardiometabolic clinic: real-world experience in lowering low-density lipoprotein cholesterol.

Internal medicine journal·2026
Same author

Inherited risk of coronary artery disease: redefining care with imaging and genetics.

Nature reviews. Cardiology·2026

Androgen receptor (AR) mRNA stability is crucial for regulating AR expression in cancers. Novel RNA-binding protein interactions with AR mRNA offer potential new therapeutic targets for prostate cancer treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Androgens, mediated by the androgen receptor (AR), are key regulators of male development and body composition.
  • AR expression is critical in prostate cancer proliferation and influences prognosis in breast cancer.
  • AR mRNA stability is a central regulatory mechanism for AR expression in cancer cells.

Purpose of the Study:

  • To review current knowledge on mechanisms regulating AR mRNA stability.
  • To explore novel AR mRNA-protein interactions, their roles, and structural biology.
  • To discuss the implications of these interactions for developing new human prostate cancer therapeutics.

Main Methods:

  • Review of existing literature on AR mRNA regulation.
  • Analysis of RNA-binding protein interactions with AR mRNA, including the 3'-untranslated region and CAG trinucleotide repeat.

Related Experiment Videos

  • Examination of the functional impact of these interactions on AR protein expression.

    • Main Results:

    • Members of the ELAV/Hu and poly(C) RNA-binding protein families bind to a conserved UC-rich element in AR mRNA's 3'-untranslated region.
    • The CAG trinucleotide repeat in AR exon 1 is a target for multiple RNA-binding proteins.
    • These interactions demonstrably impact AR protein expression levels.

    Conclusions:

    • Understanding AR mRNA-protein interactions is vital for comprehending AR regulation in cancer.
    • Novel AR mRNA-protein interactions represent promising targets for innovative prostate cancer therapies.
    • Further research into the structural biology and functional roles of these interactions could lead to significant therapeutic advancements.